RAYMOND JAMES & ASSOCIATES - TURNING POINT THERAPEUTICS I ownership

TURNING POINT THERAPEUTICS I's ticker is TPTX and the CUSIP is 90041T108. A total of 213 filers reported holding TURNING POINT THERAPEUTICS I in Q2 2022. The put-call ratio across all filers is 3.08 and the average weighting 0.4%.

Quarter-by-quarter ownership
RAYMOND JAMES & ASSOCIATES ownership history of TURNING POINT THERAPEUTICS I
ValueSharesWeighting
Q1 2022$281,000
-33.6%
10,468
+18.0%
0.00%
Q4 2021$423,000
-36.3%
8,870
-11.3%
0.00%
-100.0%
Q3 2021$664,000
-17.8%
9,998
-3.5%
0.00%0.0%
Q2 2021$808,000
-18.3%
10,361
-0.9%
0.00%0.0%
Q1 2021$989,000
-23.3%
10,451
-1.2%
0.00%0.0%
Q4 2020$1,289,000
+33.3%
10,582
-4.4%
0.00%0.0%
Q3 2020$967,000
+32.1%
11,066
-2.3%
0.00%0.0%
Q2 2020$732,00011,3320.00%
Other shareholders
TURNING POINT THERAPEUTICS I shareholders Q2 2022
NameSharesValueWeighting ↓
Cormorant Asset Management, LP 2,737,297$176,802,0006.75%
MPM BioImpact LLC 308,686$19,938,0005.30%
Burrage Capital Management LLC 77,172$4,985,0003.49%
Orbimed Advisors 2,745,327$177,321,0002.50%
Parkman Healthcare Partners LLC 110,318$7,125,0002.01%
SECTORAL ASSET MANAGEMENT INC 284,486$18,375,0001.69%
First Light Asset Management, LLC 192,829$12,455,0001.45%
Asymmetry Capital Management, L.P. 22,608$1,460,0001.12%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 35,000$2,236,0000.74%
Prosight Management, LP 25,602$1,654,0000.71%
View complete list of TURNING POINT THERAPEUTICS I shareholders